YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in

Yang Zhao1,2, Hongchao Zhao3, Danhuan Zhang4

  • 1Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.

ACS Chemical Biology
|June 16, 2022
PubMed

Insights

YTHDF3 is highly expressed in oxaliplatin-resistant colorectal cancer (CRC). It enhances gene translation by coordinating with eIF2AK2, offering a new target for overcoming chemo-resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Oxaliplatin is a key first-line chemotherapy for colorectal cancer (CRC).
  • Chemo-resistance to oxaliplatin is a significant challenge in CRC treatment.
  • N6-methyladenosine (m6A) RNA modification plays roles in various cellular functions, but its role in CRC chemo-resistance is unclear.

Purpose of the Study:

  • To investigate the role of m6A RNA-binding protein YTHDF3 in oxaliplatin resistance in CRC.
  • To elucidate the molecular mechanism by which YTHDF3 influences gene translation in chemo-resistant CRC cells.

Main Methods:

  • Analysis of YTHDF3 expression in oxaliplatin-resistant (OXAR) CRC tissues and cells.
  • Investigation of YTHDF3's interaction with m6A-modified RNAs and eukaryotic translation initiation factor 3 subunit A (eIF3A).
  • Determination of the role of eukaryotic translation initiation factor 2 alpha kinase 2 (eIF2AK2) in the YTHDF3/eIF3A complex stability.

Main Results:

  • YTHDF3 expression is elevated in OXAR CRC tissues and cells.
  • YTHDF3 binds to m6A-modified RNAs in their 5' untranslated region, promoting the translation of resistance-associated genes.
  • eIF2AK2 acts as a bridge between YTHDF3 and eIF3A, stabilizing their complex and enhancing translation in OXAR CRC cells.

Conclusions:

  • YTHDF3 is identified as a novel hallmark of oxaliplatin resistance in CRC.
  • A molecular mechanism involving YTHDF3, eIF2AK2, and eIF3A in regulating gene translation and promoting chemo-resistance is revealed.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
143.2K
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.5K
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
11.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K